Thomas DiRaimondo

Insider Reports History

Location
San Diego, CA
Signature
/s/ James Pennington, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Thomas DiRaimondo:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Janux Therapeutics, Inc. Chief Scientific Officer Common Stock 130K $7.44M $57.37 02 Jan 2025 Direct
Janux Therapeutics, Inc. Chief Scientific Officer Stock option (right to buy) 84K 02 Jan 2025 Direct

Insider Reports Filed by Thomas DiRaimondo

Symbol Company Period Transactions Value $ Form Type Role Filing Time
JANX Janux Therapeutics, Inc. 02 Jan 2025 2 $0 4 Chief Scientific Officer 03 Jan 2025, 20:10
JANX Janux Therapeutics, Inc. 27 Sep 2024 2 -$232K 4 Chief Scientific Officer 27 Sep 2024, 19:31
JANX Janux Therapeutics, Inc. 02 Jan 2024 1 $0 4 Chief Scientific Officer 03 Jan 2024, 16:47
JANX Janux Therapeutics, Inc. 01 Jan 2024 0 $0 3 Chief Scientific Officer 03 Jan 2024, 16:45